EP0178314A1 - Procede ameliore de clonage d'arn a double brin et son utilisation pour la production de clones de genes viraux - Google Patents

Procede ameliore de clonage d'arn a double brin et son utilisation pour la production de clones de genes viraux

Info

Publication number
EP0178314A1
EP0178314A1 EP19850901933 EP85901933A EP0178314A1 EP 0178314 A1 EP0178314 A1 EP 0178314A1 EP 19850901933 EP19850901933 EP 19850901933 EP 85901933 A EP85901933 A EP 85901933A EP 0178314 A1 EP0178314 A1 EP 0178314A1
Authority
EP
European Patent Office
Prior art keywords
dsrna
dsdna
virus
molecules
dsdna molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850901933
Other languages
German (de)
English (en)
Inventor
Mary Louise Skotnicki
Antek Henryk Skotnicki
Adrian John Gibbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian National University filed Critical Australian National University
Publication of EP0178314A1 publication Critical patent/EP0178314A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Definitions

  • the present invention relates to an improved method of cloning double-stranded RNA.
  • it is directed to a method of cloning double-stranded RNA and the production of cloned viral genes which can be used to detect viral infection in plants and animals.
  • the present invention can also be used to produce new plant strains which are resistant to a particular virus, or to provide immunity in animals to a specific virus.
  • ssRNA single-stranded ribonucleic acid
  • dsRNA double-stranded RNA
  • RFs replicative-form dsRNA
  • RIs replicative intermediates
  • dsRNA molecules RIs
  • ssRNA molecules which is packaged in the virus particles.
  • RIs subgenomic sizes of dsRNA molecules
  • TMV tobacco mosaic virus
  • AMV alfalfa mosaic virus
  • BYDV barley yellow dwarf virus
  • BWYV beet western yellows virus
  • Another .group of plant viruses have dsRNA genomes in the virus particles. With such viruses, there may be more than one size of RNA packaged.
  • An example of such viruses is Fiji disease virus of sugar cane, which has about ten dsRNA molecules of different sizes in its particles. These molecules can be separated, as can the RF and RI molecules, electrophoretically according to size. Certain viruses, with either ssRNA or dsRNA genomes, are only present at very low concentrations in specific tissues of infected plants.
  • luteoviruses such as BYDV and BWYV can only be found in phloem tissue and are therefore difficult to isolate in large quantities (approximately lmg of virus can be isolated from 1kg of plant tissue, and of this virus only about 20% is RNA) .
  • RNA RNA
  • these luteoviruses form dsRNA molecules, which can be isolated at concentrations of approximately 50 ⁇ g/kg plant tissue.
  • the dsRNA Fiji disease virus (FDV) is similarly located mainly in particular areas of the sugar cane plant, and is therefore also difficult to isolate in large quantities.
  • RNA viruses For further study of such RNA viruses, it would be very useful to have cloned virus genomes and single genes, as these could then be rapidly multiplied in large quantities in microorganisms rather than whole plants.
  • the low concentration of RNA means that cloning methods must be very efficient if full-length virus genomes are to be obtained.
  • RNA viruses in bacteria which contain double-stranded deoxyribonuclei ⁇ acid (dsDNA) as their genetic material
  • dsDNA double-stranded deoxyribonuclei ⁇ acid
  • cDNA single-stranded complementary DNA
  • the cDNA copy is then usually converted to a double strand of DNA using DNA polymerase or reverse transcriptase.
  • the double-stranded DNA copy can then be inserted into a bacterial DNA plasmid by standard recombinant DNA techniques, usually involving either blunt end ligation or ligation via synthetic DNA linkers or annealing after polynucleotide tailing of insert and plasmid DNA to give complementary ends.
  • dsRNA molecules could be cloned by some method other than via inefficient cDNA procedures (the only currently available method), this would facilitate cloning of full length, functional genes of viruses with ss or dsRNA genomes, and would be a particularly valuable ' technique for those viruses present at low concentrations in infected plants.
  • virus diseases There are several methods available for detection of virus diseases in plants. These include a study of the symptoms caused in test plants, microscopic examination of virus particles from infected tissue, ELISA immunological assays, and probing of infected material with virus-related nucleic acid. Of these methods, the last is the most specific, rapid, and simple test available, with the added advantage that many different samples can be tested at the same time, with quantitative results obtained in a few days or less.
  • cDNA made from isolated viral RNA
  • a labelled probe made from cloned viral genes If cDNA is used, then it is necessary to have a supply of viral RNA for this purpose. Isolation of viral RNA, even when it is present in plants in high concentrations, is a laborious and time-consuming procedure. Moreover, when virus levels are low in infected material, the isolation of RNA is even more difficult.
  • Microorganisms containing the viral inserts can be easily grown, and vectors with the inserts can be isolated and purified in large quantities by simple, rapid procedures. Virus-related inserts can then be used to manufacture probes either by nick-translation or by cDNA synthesis after DNA strand separation.
  • cloned viral gene sequences are the method of choice for probe construction. Of commercial significance, is the production of probes for virus detection in plants.
  • cloned viral genes can be used to construct probes for the detection of animal viruses and for virus-like diseases of plants and animals.
  • viral genes for the biological control of viruses is an area of great interest at present, and attempts have .been made to control viruses of plants by transferring viral genes for cross-protection into them.
  • Cross-protection also known as super-infection immunity or viral interference, is the specific resistance shown by a virus-infected host cell when attempts are made to infect it a second time with the same virus or with a closely related one.
  • the cross-protection produced by avirulent virus variants is already used as a virus control measure in certain crops. For example, it is used to control passion fruit woodiness potyvirus in passion fruit orchards, and to control citrus tristeza closterovirus in citrus crops. It was, until recently, also widely used to control tomato mosaic tobamovirus in tomato crops. Cross-protection has not been more widely used as a control measure as there has been concern that a deliberately spread avirulent virus, though protecting its chosen host, may be virulent in other species and spread to them, causing even greater problems than the original one.
  • Luteoviruses are transmitted by aphids and, although they do not replicate in the aphids, they are carried for life. Luteoviruses have isometric particles about 25nm in diameter; each contains a genome, which consists of a single molecule of single-stranded RNA with a molecular weight of about 2 million. They replicate only in plant phloem cells and hence the virions attain very small - total concentrations in plants. They disrupt translocation in infected plants, causing yellowing, reddening and leaf rolling.
  • Luteoviruses can be effectively controlled by treating crops with insecticides or by destroying virus and aphid sources.
  • these methods are suitable for controlling luteoviruses of intensively-grown high-value crops such as sugar beet or potatoes, they are not economical for large acreage low-value crops such as cereals or pastures.
  • Naturally occurring resistance genes have been found and moved into desirable cultivars of some crop species using standard plant breeding methods. The process is very time-consuming, and it has often proved difficult to conserve other desirable characters (e.g. resistance to other pathogens). Resistance of this sort has been bred into sugar beet for controlling luteovirus losses and barley yellow dwarf virus
  • dsRNA cloning methods can be used to obtain single functional virus genes. These can then be linked, using standard recombinant DNA techniques, to a promoter which functions in plant cells, thereby enabling the viral gene product to be manufactured in plant cells.
  • the linked promoter viral gene construct can then be transferred into a modified tumour-inducing (Ti) plasmid of Agrobacterium, in such a way that, on infection of appropriate plant cells, the viral gene construct is incorporated into the plant genome together with parts of the Ti plasmid vector.
  • Ti tumour-inducing
  • Plants thus obtained will have the viral gene present in cells throughout the whole plant, and these can be tested for resistance to infection by the same or related viruses. Plants with the cross-protection gene(s) inserted will resist superinfection with such viruses.
  • cross-protection is also known to operate -among viruses of animals. Therefore, the molecular introduction of cross-protecting viral genes is applicable to animals as well as plants.
  • Cloned viral dsRNA can be used to obtain large quantities of very pure RNA and protein encoded by the cloned gene, by in vitro transcription and translation of the DNA insert.
  • the RNA thus obtained can be used for infectivity tests on plant material, either alone or in combination with other viral RNAs.
  • the protein can be used for in vitro packaging tests of viral genetic material, or for production of specific antisera. This is of importance in the production of specific antisera made from pure viral proteins, particularly proteins not normally isolated in large quantities from infected cells.
  • cloned genetic material is essential for sequencing of the viral genomes.
  • the dsRNA of RFs and RIs is most useful for cloning single, functional units for gene sequencing. Where levels of viral RNA are low, and where the whole viral genome has not been sequenced, clones obtained from dsRNA should facilitate identification and sequencing of these viral genes. Sequencing is a research tool for understanding the makeup of the genome and the way in which it functions.
  • direct cloning it is meant that viral dsRNA is itself ligated to the dsDNA of cloning vectors to be subsequently used for transformation in recipient cells such as Escherichia coli, rather than first making a cDNA copy of the RNA molecule.
  • recipient cells such as Escherichia coli
  • a second object is the use of this direct cloning of dsRNA to construct probes for the detection of virus diseases.
  • a third object is the use of direct dsRNA cloning to obtain functional viral genes which can be transferred to plants to confer specific resistance to particular viruses, free from the potential problems that come from the use of avirulent virus variants.
  • the present invention allows the laborious step of producing double-stranded DNA copies in. vitro to be eliminated by allowing double-stranded RNA to be cloned instead of DNA.
  • a method of direct insertion of the double-stranded RNA into a cloning vector consisting of double-stranded DNA comprising:
  • the dsRNA molecules can be first tailed, for example, with poly-A or poly-C, and then ligated to plasmid dsDNA which, in turn, has also been tailed with, for example, poly-dT or poly-dG.
  • homopolymer DNA tails must be added to the ends of the plasmid DNA which are complementary to the homopolymer RNA tails added to the dsRNA.
  • the tailed dsRNA and plasmid dsDNA are then subjected to annealing by conventional techniques.
  • the dsRNA can also be directly ligated to dsDNA by first ensuring that all ends of the dsRNA are completely blunt. The blunt-ended dsRNA is then ligated to a suitable blunt-ended DNA plasmid, once again, using standard techniques well-known in the art for blunt-end ligation.
  • the plasmid with dsRNA inserts can be transformed into recipient cells such as Escherichia coli by standard techniques well known in the art.
  • the transforments thus-produced can be isolated by methods also well known in the art, but preferably, by Southern hydridization or antibiotic sensitivity.
  • dsRNA Direct cloning of dsRNA is most useful in two main situations: where very low amounts of RNA are available, or where single, functional genes are required.
  • the method of the present invention can be used to obtain cloned viral genes for a variety of purposes such as: i) nucleic acid probes for viral infections, particularly where low levels of virus are present in the infected tissue; ii) functional genes isolated from the whole viral genome for insertion into host plant genomes for viral cross-protection; iii) production of large amounts of viral RNA, by in vitro transcription; iv) viral gene sequencing; v) in vitro protein production from cloned viral genes via in vitro transcription and translation.
  • the dsRNA cloning method of the present invention is a simple method for obtaining inserts suitable for use as probes.
  • clones of AMV, TMV and FDV obtained from dsRNA have been used to probe plant material which was either known or suspected to be infected with the appropriate virus.
  • dsRNA cloning method with ssRNA molecules, if these are first converted to dsRNA (rather than cDNA) with an enzyme such as RNA-dependent RNA polymerase or reverse transcriptase.
  • Virus infection can cause a crop loss in, for example, alfalfa of 2-5% which should be overcome if the alfalfa mosaic virus cross-protection gene is inserted.
  • the present invention is applicable to cross-protection against tobacco mosaic virus in tobacco and tomatoes, beet western yellows virus in sugarbeet and soybeans and barley yellow dwarf virus in barley, wheat, rice and oats.
  • tobacco mosaic virus in tobacco and tomatoes
  • beet western yellows virus in sugarbeet and soybeans
  • barley yellow dwarf virus in barley, wheat, rice and oats.
  • the technique could be equally well applied to a wide range of other viruses which infect plants or animals.
  • Virus-infected plants were homogenized in an appropriate buffer (eg. 50mM Tris, lOOmM NaCl, ImM EDTA, pH 7.0) containing a small amount of mild detergent (eg. 2% w/v SDS) and an antioxidizing agent (eg. 1% v/v 2-mercaptoethanol) .
  • the slurry was further homogenized with phenol, and then clarified with chloroform. After a low-speed centrifugation, ethanol was added to the aqueous phase to 15% v/v final concentration. under these conditions, dsRNA is preferentially bound to a Whatman CFll cellulose column and can be subsequently eluted in the absence of ethanol. Routinely, two CFll columns were used to bind and ' elute the viral dsRNA.
  • the eluted nucleic acids were treated with DNAse to remove any traces of DNA.
  • the dsRNA was then phenol-chloroform extracted and precipitated with 0.3M sodium acetate and ethanol to purify and concentrate it.
  • the dsRNA molecules were fractionated by electrophoresis in polyacrylamide or agarose gels and distinct sizes were eluted from the gels.
  • Fiji disease virus dsRNA was extracted directly from galls of infected sugarcane following a procedure similar to that described above for RFs and RIs.
  • dsRNA was treated with tobacco acid phosphatase (TAP) from Bethesda Research Laboratories to remove any possible ".cap” structures from the ends of the molecules. The presence of such structures might inhibit ligation of these molecules to dsDNA.
  • TAP tobacco acid phosphatase
  • the decapping reaction was carried out as described by Bethesda Research Laboratories in 50mM sodium acetate buffer pH5.0 in the presence of lOmM 2-mercaptoethanol and ImM EDTA, for 60 minutes at 37 C. After extraction with phenol and ethanol precipitation, the dsRNA molecules were treated with polynucleotide kinase to restore phosphate groups to the 5'-OH termini prior to ligation. In general, the decapping procedure was not found to affect ligation of dsRNA to DNA molecules.
  • Synthetic dsDNA linkers were first phosphorylated using T4 polynucleotide kinase. These were then ligated to the dsRNA (blunt end ligation) using T4 DNA ligase and T4 RNA ligase. High concentrations of linkers (up to 0.2 ug/10 ul) and both ligases (up to 8U RNA ligase and 200U DNA ligase/lOul) were used to ensure that ligation proceeded as far as possible. In these experiments, Bam HI and Eco RI linkers were used but a variety of other synthetic molecules could be used in a similar manner.
  • the ligases were inactivated at 65 C and the linkers were cut with the appropriate restriction enzyme (in this example Bam HI or Eco RI). Under standard conditions for restriction enzymes, these enzymes were not observed to cut dsRNA molecules. Therefore only the DNA linkers, not the dsRNA, should be cut when a sequence is recognised by the restriction enzyme.
  • the appropriate restriction enzyme in this example Bam HI or Eco RI.
  • Plasmid DNA (eg. pBR322, pBR325) was isolated, from E. coli strain RR1, purified on Cs Cl gradients, and cut with the appropriate restriction enzyme.
  • the linear DNA was purified by elution of the band formed on an agarose gel. It was then usually treated with calf intestine alkaline phosphatase to remove termal 5' phosphates, to prevent self-ligation and thereby minimize the background of non-recombinant plasmids.
  • the dsRNA molecules with attached linkers, after cutting with restriction enzymes, were ligated to appropriate linearized plasmid DNA with T4 DNA ligase.
  • dsRNA molecules were tailed with poly-A or poly-C, the ss tails being 20-100 nucleotides long.
  • Poly(A) polymerase was used to add AMP (derived from ATP) or CMP (from CTP) on to the free 3 '-OH termini of the dsRNA. molecule.
  • the reaction was carried out in a buffer containing 50mM Tris pH 7.6, 1 mM dithiothreitol, 10 mM MgCl 2 , 0.2 mM rATP, 0.2M NaCl and 2.5mM MnCl_ at 37° for 15 min.
  • the number of AMP or CMP molecules added o the 3' ends of the RNA was monitored by using H-rATP or 3 H-rCTP.
  • Pstl-cut, linear plasmid molecules were tailed with dT or dG residues, the tails being 20-100 nucleotides in length. Terminal transferase was used to catalyze the addition of deoxynucleotides to the 3'-OH termini of the DNA molecule. The number of deoxynucleotides added to the 3 1 ends of the plasmid DNA was monitored by using 32P-dATP and 32P-dCTP, and then similar conditions were used with unlabelled dTTP and dGTP to obtain 20-100 nucleotide tails. With this treatment, homopolymer DNA tails were added to the ends of the plasmid molecule which were complementary to the homopolymer RNA tails added to the dsRNA.
  • RNA and DNA were heated to 65 C for 5 min, incubated at 57 C for 2h and then cooled slowly to room temperature in annealing buffer.
  • the RNA and DNA were present at final concentrations of approximately lug/ml in the annealing mixture.
  • dsRNA was treated in DNA repair buffer with 10U/20ul DNA polymerase (Klenow fragment) in the presence of all four 0.1M dNTPs to ensure that the ends were completely blunt.
  • the dsRNA was treated with SI nuclease (500-1000 units at room temperature for 30 min) to remove any ssRNA ends.
  • SI nuclease 500-1000 units at room temperature for 30 min
  • a plasmid such as pUC8 was cut with a restriction enzyme such as Smal, to give a blunt-ended linear molecule. This was then ligated to the dsRNA using high concentrations of T4 DNA ligase and T4 RNA ligase as described above for ligation of synthetic linkers.
  • the constructed plasmids were transformed into Escherichia coli strain RR1. Clones with viral gene inserts were isolated from the colonies obtained by Southern hybridization with a radioactive cDNA probe made from viral RNA with reverse transcriptase and random primers.
  • the dsRNA inserts are converted to dsDNA during plasmid replication. After plasmid reisolation, the inserts can then be cut with restriction enzymes and treated in the same way as clones obtained by traditional cDNA methods.
  • AMV-related dsRNA molecules were isolated from Nicotiana tabacum var. Samsun and from N. tabacum var. White Burley. Up to 7 different sized dsRNA molecules were detected on 10% Laemmli acrylamide gels, with a size range of approximately 0.5 kilobases (kb) to 4 kb. The relative concentration of dsRNA molecules of different size varied depending on the variety of N. tabacum used, and the time of isolation after infection of plants with AMV.
  • AMV dsRNA molecules have been cloned by the addition of synthetic DNA linkers, or by tailing of molecules.
  • Bam HI dsRNA linkers were ligated directly to the dsRNA.
  • the ligated molecules were digested with the restriction enzyme Bam HI, which only recognized Bam HI- DNA sequences and not RNA " sequences, thereby avoiding the digestion of AMV genes which contain Bam HI recognition sites. (For example,- if standard cDNA techniques had been used, Bam HI would have cut the AMV3 cDNA copy, but this did not occur with the dsRNA gene, which is another advantage of cloning dsRNA directly) .
  • AMV dsRNA molecules were also cloned by polynucleotide tailing. Single-stranded poly-A or poly-C tails were added to the 3' ends of the RNA using poly(A) polymerase from E. coli. This enzyme is normally used to add poly-A tails to 3' ends of ssRNA molecules prior to cDNA synthesis primed with a complementary poly-dT primer. However, it has been found that the same enzyme preparation can add poly-C tails, albeit less efficiently than poly-A, to the 3' ends of dsRNA molecules.
  • AMV dsRNAs with poly-A tails were annealed with plasmid pBR322 cut with restriction enzyme Pst I and treated with terminal transferase to add poly-dT tails approximately 20-100 nucleotides in length.
  • AMV dsRNAs with poly-C tails were annealed with Pst I cut pBR322 with poly-dG tails. The latter reaction has the advantage that a Pst I site can be recreated at each end of the AMV insert, allowing later removal of the insert from the plasmid DNA for further study.
  • AMV dsRNA clones Many different AMV dsRNA clones have been obtained by these methods.
  • the most efficient method of cloning the dsRNA is by addition of poly-A tails.
  • TMV dsRNA molecules have been isolated from N. tabacum var. Samsun and separated on 10% Laemmli gels. These dsRNAs, like those of AMV, have been cloned after addition of poly-A tails using E. coli poly(A) polymerase.
  • TMV dsRNA clones A variety of TMV dsRNA clones have been obtained by this method.
  • Fiji disease virus genomic dsRNA was isolated directly from infected sugarcane.
  • the dsRNA was separated on a 10% Laemmli acrylamide gel, and RNA sizes ranged from approximately 3.5 kb to 9 kb.
  • the dsRNA could be directly cloned by the addition of DNA linkers, by tailing of molecules, or by direct blunt-end ligation into a plasmid.
  • FDV dsRNA has been cloned by addition of Bam HI linkers or Eco RI linkers, followed by digestion with the appropriate restriction enzyme and ligation into Bam Hi-cut pBR322 or Eco Rl-cut pBR325 respectively. Selection of clones with FDV inserts was by Southern hybridization with a FDV cDNA probe. The clones with FDV sequences were then purified and further characterized.
  • FDV dsRNA has also been cloned directly after addition of poly-A tails by annealing with Pst I-cut ⁇ BR322 tailed with poly-dT, as described above for AMV dsRNA. ' Different FDV clones were identified by Southern hybridization with a FDV cDNA probe.
  • RNA can be isolated either from virus particles or directly from infected tissue.
  • double-stranded RNA from any source can be used to clone genes directly rather than using DNA copies.
  • a number of different clones of plant virus genes have been obtained by the method of the present invention as described above.
  • single genes of alfalfa mosaic virus have been cloned from double-stranded RNA by addition of Bam HI linkers and insertion into Bam Hl-cut ⁇ BR322 plasmid, and also by polynucleotide tailing and insertion in the Pst I site of pBR322.
  • probes for TMV, FDV, BYDV and BWYV can be readily produced by the method of the present invention.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

Procédé d'insertion directe d'ARN à double brin dans un vecteur de clonage formé d'ADN à double brin, comportant a) l'isolation du dsARN à partir d'une source d'intérêt; b) si nécessaire, le décalottage du dsARN; et c) la ligature directe du dsARN au dsADN du vecteur de clonage approprié. Ce procédé permet le clonage direct du dsARN, éliminant ainsi l'étape traditionnelle consistant à faire tout d'abord une copie par ADN complémentaire de la molécule d'ARN. Grâce à ce procédé, il est possible de construire des sondes pour la détection d'affections virales chez les plantes et les animaux. Ce procédé peut également être utilisé pour produire de nouvelles souches végétales résistantes à un virus particulier, ou pour conférer aux animaux l'immunité à un virus spécifique.
EP19850901933 1984-04-26 1985-04-26 Procede ameliore de clonage d'arn a double brin et son utilisation pour la production de clones de genes viraux Withdrawn EP0178314A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU4708/84 1984-04-26
AU470884 1984-04-26

Publications (1)

Publication Number Publication Date
EP0178314A1 true EP0178314A1 (fr) 1986-04-23

Family

ID=3695176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850901933 Withdrawn EP0178314A1 (fr) 1984-04-26 1985-04-26 Procede ameliore de clonage d'arn a double brin et son utilisation pour la production de clones de genes viraux

Country Status (2)

Country Link
EP (1) EP0178314A1 (fr)
WO (1) WO1985004898A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201444T1 (de) * 1985-03-21 2001-06-15 Johnston Stephen Ph D Vom parasit abgeleiteter widerstand
US5580716A (en) * 1985-03-21 1996-12-03 Stephen A. Johnston Parasite-derived resistance
US6608241B1 (en) 1985-10-29 2003-08-19 Monsanto Technology Llc Protection of plants against viral infection
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
EP0920526B1 (fr) * 1997-06-12 2004-11-24 Sloan-Kettering Institute For Cancer Research Assemblage covalent de brins d'adn a des brins d'arn catalyse par une vaccinia topoisomerase
WO2001062943A1 (fr) 2000-02-25 2001-08-30 Invitrogen Corporation Techniques d'amplification induites par des lieurs de topoisomerase
ATE315086T1 (de) 2000-08-21 2006-02-15 Invitrogen Corp Methoden und reagenzien für molekulares klonieren
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20060008817A1 (en) 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
WO2002061034A2 (fr) 2000-12-08 2002-08-08 Invitrogen Corporation Compositions et methodes permettant de produire rapidement des molecules d'acide nucleique recombinees
WO2005054438A2 (fr) 2003-12-01 2005-06-16 Invitrogen Corporation Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8504898A1 *

Also Published As

Publication number Publication date
WO1985004898A1 (fr) 1985-11-07

Similar Documents

Publication Publication Date Title
Zinder et al. The filamentous phage (Ff) as vectors for recombinant DNA—a review
AU594665B2 (en) Phenotypic modifications of host cells via RNA transformation vector
Davanloo et al. Cloning and expression of the gene for bacteriophage T7 RNA polymerase.
KR101994953B1 (ko) 침입성 dna 바이러스에 대해 식물 내성을 강화하는 방법
US5169770A (en) Agrobacterium mediated transformation of germinating plant seeds
US5300431A (en) Positive selection vector for the bacteriophage P1 cloning system
CN87100463A (zh) 植物病毒或其作用的改变
EP0178314A1 (fr) Procede ameliore de clonage d'arn a double brin et son utilisation pour la production de clones de genes viraux
CN114729357A (zh) 调节植物开花的rna分子
EP0513054B1 (fr) Genes de resistance aux virus/herbicides, leur procede de production et leur utilisation
CZ291203B6 (cs) DNA-konstrukty propůjčující rezistenci vůči virům, rostliny které je obsahují a způsob jejich přípravy
CN120555484B (zh) 类受体激酶MdRLK2在苹果综合抗性育种中的应用
Sam et al. DESIGN AND TRANSFER OF OsSWEET14-EDITING T-DNA CONSTRUCT TO BAC THOM 7 RICE CULTIVAR.
KR100260483B1 (ko) Rna 비루스에 대하여 저항성을 갖는 식물 제조방법
CN115873828B (zh) 基因编辑系统及其应用
AU4296585A (en) An improved method of cloning double-stranded rna, and its use in the production of viral gene clones
WO2024053677A1 (fr) Procédé d'édition génomique pour gènes dupliqués
Rowen et al. Cloning of bacterial DNA replication genes in bacteriophage λ
Ravin et al. Complete sequencing of potato virus X new strain genome and construction of viral vector for production of target proteins in plants
Houwing et al. Activation of the alfalfa mosaic virus genome by viral coat protein in non-transgenic plants and protoplasts. The protection model biochemically tested
Tousignant et al. Cucumber mosaic virus-associated RNA 5: XIII.—Opposite necrogenicities in tomato of variants with large 5′ half insertion/deletion regions
CN119220594B (zh) 烟草NtTIRd基因及其应用
Carpenter et al. Mutations in a satellite RNA of turnip crinkle virus result in addition of poly (U) in vivo
KR0180274B1 (ko) 담배 모자이크 바이러스의 복제효소 내에 존재하는 도메인 1 염기 서열을 이용한 바이러스 저항성 식물의 개발
Wu Two Circular Single‐stranded DNAs Associated with Banana Bunchy Top Virus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19860401

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SKOTNICKI, MARY, LOUISE

Inventor name: SKOTNICKI, ANTEK, HENRYK

Inventor name: GIBBS, ADRIAN, JOHN